Additionally, C21ORF123 promoter methylation has been implicated in cisplatin resistance in non-small cell lung cancer and RIN1 is a tumor suppressor that is deregulated through aberrant promoter methylation in breast cancer [60,61]. This evidence concerns the gene COL18A1-AS1 and breast carcinoma.